logo
Docs seek action as post-Covid neurological disorders rise in Mysuru

Docs seek action as post-Covid neurological disorders rise in Mysuru

Time of India3 days ago
1
2
3
Mysuru: Following the state govt's move to form an expert committee to investigate a surge in sudden cardiac deaths, Mysuru-based neurologists have urged similar action to address the alarming rise in neurological disorders post-Covid-19.
Dr Shushrutha Gowda, an American board-certified neurologist, reports a 30% increase in such cases, aligning with international findings that indicate a multifold rise in cities like Mysuru. He said that even though brain-related disorders are increasing, there is no effort to address them.
Dr Gowda highlighted a significant uptick in conditions such as migraines, neuropathy, stroke, and dementia compared to pre-Covid times.
"Neurological disorders are often more severe than cardiac issues, with higher morbidity rates. The urgency to conduct comprehensive studies and implement interventions cannot be overstated," he said. He emphasized the need for immediate action to understand and mitigate these health challenges.
Citing recent cases, Dr Gowda noted treating an 18-year-old diabetic smoker for stroke, one of the youngest such patients, and dementia cases in individuals as young as 45.
Diabetic persons with smoking habits are more vulnerable to neuro disorders. There is a need to take up a drive to educate society on brain health, he said.
To tackle this growing crisis, he proposed statewide epidemiological surveys, regional neurology registries, and funding for research into dementia risk factors and treatments. He advocated for an integrative approach to develop effective solutions.
Dr Mohamed Ataulla Shariff, consultant-neurology, Narayana Hospital, Mysuru, observed that post-Covid-19, neurological conditions like Guillain-Barré syndrome and ischemic strokes have seen an increasing trend.
Many patients have shown cognitive decline (brain fog), fatigue, muscle aches, and pains. Due to steroid usage in the treatment of Covid, patients developed diabetes leading to a few neurological complications like sensory changes such as numbness and tingling, he explained.
Dr Sucharitha MV, associate consultant-neurology, Manipal Hospital, Mysuru, said initially post-Covid, they did see a spike in acute ischemic strokes, cerebral haemorrhage, cerebral venous thrombosis, and encephalitis.
Other common problems encountered by many patients were anosmia (loss of smell), altered taste, fatigue, headaches, dizziness, and myalgia. Over a span of a year, many patients recovered completely, while others did not return to their near normal but have shown gradual improvement.
There hasn't been a drastic spike in new cases, but patients with pre-existing neurological disorders, such as Parkinson's disease, dementia, and epilepsy, who worsened during Covid have often not returned to their pre-Covid baseline.
As a delayed complication of Covid, many patients suffer from memory loss, behavioural issues, depression, and fatigue, she said. In the acute phase, patients had an increased risk of ischemic stroke, intracerebral haemorrhage, and cerebral venous thrombosis, she said.
According to health department officials, the rise in the number of neurological disorders can be ascertained only when the cases are reported to the hospitals, and till now no sudden spike in the cases has been reported. Mysuru district health officer Dr PC Kumaraswamy stated that the mental health programme currently includes brain health initiatives focusing on disorders like dementia. However, he claimed no significant spike in neurological cases has been observed locally.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Recruitment of contract staff nurses through DHS comes under fire
Recruitment of contract staff nurses through DHS comes under fire

The Hindu

time36 minutes ago

  • The Hindu

Recruitment of contract staff nurses through DHS comes under fire

Facing huge vacancies across various posts, the Health department is now planning to fill up vacant posts of contract staff nurses through the District Health Society (DHS) on an 11-month contractual appointment basis. However, the Tamil Nadu Nurses Empowerment Association has called this a deviation from existing norms, as contractual posts of nurses were so far filled with nurses recruited through the Medical Services Recruitment Board (MRB). An official communication referred to the meetings conducted by the Health Secretary with the respective heads of departments to review vacancies in various posts across the health directorates. The huge vacancy position in the post of staff nurse in each directorate was reviewed and concerns were expressed over addressing the issue without delay. Considering the huge number of vacancies in the posts of contract staff nurses, an instruction to explore filling up the posts on a contract basis through the DHS was issued. Temporary/scheme/contract posts of staff nurse, pharmacist, and lab technician grade III on a contract basis should be filled up through the DHS, as is being done for other categories of temporary/scheme/contract posts. District Health Officers (DHO) should take an estimate of all vacancies in the contract post of staff nurse, pharmacist and lab technician grade III sanctioned for National Health Mission (NHM), Tamil Nadu and take immediate steps to fill in a time-bound manner. They were told to strictly follow the contract norms while issuing appointment orders to the selected candidates on a contractual basis - contract appointment is for 11 months only and a declaration that the contractual appointment is purely temporary should be obtained. N. Subin, general secretary, Tamil Nadu Nurses Empowerment Association, said that until now, nurses recruited through the MRB were posted to the NHM's contract posts. 'Nurses, who qualify through MRB, are posted on a contractual basis. As per norms, those not below two years of service are brought to timescale pay as and when vacancies in regular posts arise. Instead of the usual procedure, the Health Department is now going to make contractual appointments for 11 months. There will be no permanency in posts if this materialises,' he said. In a statement issued, the association said there were nearly 4,000 vacant posts of contract nurses, pharmacists and lab technicians across all three directorates. The order issued by NHM, Tamil Nadu to fill these vacancies on an 11-month contractual basis through the DHS would affect the State's health sector. The association said that it is shocking that the department, despite a court order to reinstate nearly 700 nurses who were recruited through MRB for COVID-19, has gone ahead to fill the vacant posts through DHS instead of posting them. They demanded the State government to drop the move and recruit nurses and other staff through the MRB.

Work on HC-ordered CDSCO panel on weight loss drug may begin mid-July
Work on HC-ordered CDSCO panel on weight loss drug may begin mid-July

Business Standard

time3 hours ago

  • Business Standard

Work on HC-ordered CDSCO panel on weight loss drug may begin mid-July

A Delhi HC directive to examine unregulated use of weight loss drugs may lead to a CDSCO expert panel by mid-July, possibly led by DCGI with pharma and govt representation New Delhi The Central Drugs Standard Control Organisation (CDSCO) may begin work on forming a court-ordered expert panel to examine the unregulated use of weight loss drugs by mid-July, according to sources. Officials in the know told Business Standard that the panel could be led by the Drug Controller General of India (DCGI) and may include the Director General of Health Services (DGHS) and officials from the Department of Pharmaceuticals as members. 'There are discussions that pharmaceutical associations would be asked to join as well to give an industry viewpoint,' an official aware of the matter said. The CDSCO did not respond to queries emailed by Business Standard till the time of going to print. The panel is also expected to review the possible unregulated use of anti-diabetic drugs for weight loss within the court's three-month deadline to respond to the petitioner. The directive followed a Public Interest Litigation (PIL) filed by fitness entrepreneur Jitendra Chouksey, raising concerns over the marketing approval granted for drugs such as semaglutide, tirzepatide and liraglutide for weight management despite limited safety data and a lack of India-specific clinical trials. The direction comes amid a wave of weight loss drug launches by multinational pharmaceutical companies in India. US-based Eli Lilly launched Mounjaro (tirzepatide) in March, while Danish drugmaker Novo Nordisk launched Wegovy (semaglutide) last month. These drugs, administered as once-a-week injections, belong to a class of therapies known as glucagon-like peptide-1 (GLP-1) receptor agonists, which help regulate blood sugar and slow digestion, making users feel full for longer. According to standard guidelines for obesity management medications (OMMs), weight loss drugs are approved for patients with a Body Mass Index (BMI) over 27 and at least one obesity-related comorbidity, such as Type-2 diabetes, hypertension or high cholesterol. However, doctors report growing interest from individuals who do not meet the medical criteria. 'We are strictly discouraging its use for cosmetic purposes or in patients who do not meet the clinical threshold,' a Delhi-based endocrinologist said.

No Link Between Covid Vaccine & Sudden Cardiac Deaths: Karnataka Govt Research Amid Hassan Surge
No Link Between Covid Vaccine & Sudden Cardiac Deaths: Karnataka Govt Research Amid Hassan Surge

News18

time3 hours ago

  • News18

No Link Between Covid Vaccine & Sudden Cardiac Deaths: Karnataka Govt Research Amid Hassan Surge

Dr KS Ravindranath, Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, said, 'We haven't seen a direct link between vaccine or COVID and heart attacks." Amid the surge in heart attack fatalities in Hassan district, a research commissioned by the Karnataka government prior to the incident has found no causal link between Covid-19 vaccines and sudden cardiac deaths. The report has attributed the rise to an increase in conventional risk factors such as hypertension, obesity, and diabetes. Speaking to CNN-News18, Dr KS Ravindranath, Director of the Sri Jayadeva Institute of Cardiovascular Sciences and Research, said, 'We haven't seen a direct link between vaccine or COVID and heart attacks." 'Risk factors have gone up post Covid' Dr Ravindranath highlighted that their observational pilot study at Jayadeva Hospital, examining over 200 patients under 45 in April and May, did not find an association between premature cardiovascular disease and a prior history of COVID-19 infection or vaccination. But he highlighted that the risk factors had gone up significantly post COVID. 'Post-Covid, we have seen a 6-8% increase in other risk factors such as hypertension, obesity, diabetes, etc.," Dr Ravindranath noted, emphasising the shift in risk profiles. He further clarified that these increases are also observed in younger demographics (20-30 year olds), attributing it to stress, lifestyle changes, and potential hormonal shifts post-Covid, alongside job losses. 'Hassan incident in line with broader trend' Regarding the ongoing probe into deaths in Hassan district, Dr Ravindranath clarified that it's not an isolated epidemic, but rather in line with broader trends. 'What we have seen is that most of the private hospitals there, if you look at most of the people admitted there due to heart attacks, 200 plus," he explained. 'Any heart attack has a 5-6% mortality rate, up to 8% sometimes, in that range, mortality is known. So when the numbers are more, obviously the deaths are severe." He added that India's incidence of heart attacks has generally risen compared to Western countries, occurring about 10 years earlier on average. The report's recommendations include establishing a cardiac surveillance program, a national registry for sudden cardiac deaths among young adults, routine heart screenings at the school level, and public health campaigns promoting healthy lifestyles to address the growing burden of cardiovascular diseases. On Karnataka CM Siddaramaiah speaking on the possible link between the vaccine and heart attack, Dr Ravindranath said that a member of civic society had petitioned the CM. 'There is a belief among people and health professionals that they are linked. So to clear the doubts of the public, he had asked whether the vaccine could cause it. The expert committee did not find a link," he said. 'Need for post-mortem' Dr Ravindranath stressed on the ⁠need for post-mortem for cases of heart failures, registry of sudden cardiac deaths of youngsters, health checks of high school children to discern heart-related issues. On the Hassan case, he said, 'We have asked for details and sent a questionnaire to the local health officials to understand what happened there…Compared to Western countries, heart attacks take place in India 10 years younger. ⁠We have seen a 15 per cent increase in youngsters coming to Jayadeva to check on their heart function." Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : anti covid vaccine cardiac arrest heart attacks news18 specials Location : Bengaluru, India, India First Published: July 07, 2025, 17:15 IST News india No Link Between Covid Vaccine & Sudden Cardiac Deaths: Karnataka Govt Research Amid Hassan Surge

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store